Karachi: GlaxoSmithKline Pakistan Limited (GLAXO) reported significant financial growth in its corporate briefing session, highlighting a 7.7% increase in net revenue to PkR65.9 billion for the calendar year 2025. The session also revealed a 53.4% year-on-year surge in profit after tax (PAT), reaching PkR10.0 billion.

According to AKD Securities Limited, GLAXO's gross margins expanded to 37.0% in 2025 from 25.1% in the same period last year, attributed to the deregulation of its non-essential portfolio and measures for profit sustainability. Despite this growth, the company experienced a decline in other income, which fell to PkR1.4 billion from PkR2.8 billion in the previous year. This decrease was largely due to a reduction in promotional allowance, which dropped to PkR615 million from PkR2.1 billion in the same period last year.